Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis

Putri, Kurnia S. S.; Adhyatmika, Adhyatmika; Boorsma, Carian E.; Habibie, Habibie; Ruigrok, Mitchel J. R.; Heukels, Peter; Timens, Wim; de Jager, Marina H.; Hinrichs, Wouter L. J.; Olinga, Peter; Melgert, Barbro N.

doi:10.1007/s00408-024-00691-5

Cited by 1 publication

(1 citation statement)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One plausible explanation for the observed fibrotic characteristics in our model is that the slicing of the lungs to generate PCLS functions as an injury, which then activates an intrinsic wound healing response in the tissue. This has been suggested previously [47], and may also explain why we see increased expression of some markers in our control PCLS, including FN1, Arginase activity, and Arg-1 IHC, compared to baseline.…”

Section: Discussionsupporting

confidence: 84%

A NovelEx VivoApproach for Investigating Profibrotic Macrophage Polarization Using Murine Precision-Cut Lung Slices

Vierhout,

Ayoub,

Ali

et al. 2024

Preprint

View full text Add to dashboard Cite

Idiopathic pulmonary fibrosis (IPF) is fatal interstitial lung disease characterized by excessive scarring of the lung tissue and declining respiratory function. Given its short prognosis and limited treatment options, novel strategies to investigate emerging experimental treatments are urgently needed. Macrophages, as the most abundant immune cell in the lung, have key implications in wound healing and lung fibrosis. However, they are highly plastic and adaptive to their surrounding microenvironment, and thus to maximize translation of research to lung disease, there is a need to study macrophages in multifaceted, complex systems that are representative of the lung. Precision-cut lung slices (PCLS) are living tissue preparations derived from the lung that are culturedex vivo,which bypass the need for artificial recapitulation of the lung milieu and architecture. Our objective was to establish and validate a moderate-throughput, biologically- translational, viable model to study profibrotic polarization of macrophages in the lung using murine PCLS. To achieve this, we used a polarization cocktail (PC), consisting of IL-4, IL-13, and IL-6, over a 72-hour time course. We first demonstrated no adverse effects of the PC on PCLS viability and architecture. Next, we showed that multiple markers of macrophage profibrotic polarization, including Arginase-1, CD206, YM1, and CCL17 were induced in PCLS following PC treatment. Through tissue microarray-based histological assessments, we directly visualized and quantified Arginase-1 and CD206 staining in PCLS in a moderate-throughput manner. We further delineated phenotype of polarized macrophages, and using high-plex immunolabelling with the Iterative Bleaching Extends Multiplexity (IBEX) method, showed that the PC effects both interstitial and alveolar macrophages. Substantiating the profibrotic properties of the system, we also showed expression of extracellular matrix components and fibrotic markers in stimulated PCLS. Finally, we demonstrated that clodronate treatment diminishes the PC effects on profibrotic macrophage readouts. Overall, our findings support a suitable complex model for studying ex vivo profibrotic macrophage programming in the lung, with future capacity for investigating experimental therapeutic candidates and disease mechanisms in pulmonary fibrosis.

show abstract

Section: Discussionsupporting

confidence: 84%